Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX03 vs adalimumab for moderate-to-severe plaque psoriasis
CTR20171123Phase 3Completed
- Sponsor
- Henlius
- Start
- Nov 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of handayuan in psoriasis, sponsored by Henlius. Started Nov 2017; status: completed.
02
Drugs
handayuan
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20171123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171123.